“Shares of the tiny biotechnology company Mustang Bio Inc. more than tripled Thursday, following a scientific breakthrough that cured eight infants suffering from the devastating “Bubble Boy” immune system disorder.”
Fantastic development in gene therapy for a rare but, well known disease. Cool company. Well done, MustangBio team!
Read full article in Bloomberg HERE